American Oncology Network, Inc. (AONC) - Revenue and Sales Volume

American Oncology Network, Inc. - graphic logo of issuer AONC

American Oncology Network is implementing high-tech data analytics to optimize targeted therapy. The company is building an infrastructure that integrates private practices with pharmacies and laboratories to support physicians. The community oncology network ensures a steady patient flow under strict Medicare oversight. The company's sales structure and volume demonstrate financial dynamics where 1.02 expresses the metric value today.

Revenue and Sales Volume: American Oncology Network Inc (AONC) for 02/21/2024 - 08/04/2024

Comprehensive metric breakdowns and analytics for American Oncology Network, Inc. (AONC)

- market capitalization indicators:
Summary company analysis:AONC American Oncology Network, Inc.
Flagship merchandise of aoncology.com

The defensive nature of the medical business of American Oncology Network (AONC) ensures stable demand for critical services that remains independent of macroeconomic fluctuations. An analysis of the company's sales agility allows for the real-time tracking of daily revenue inflows, eliminating quarterly lags and helping investors recognize trend reversals in a timely manner to minimize capital drawdown risks.

Key competitors

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|Renovaro - Company Sales Volume|Company Revenue Mural Bio MURA|KAPA: Company Sales Volume|OnKure Therapeutics - Revenue and Sales Volume|Company Gross Revenue w2.cytomed.sg GDTC|CRIS: Revenue and Sales Volume|Company Sales Apollomics Inc.|THAR (Tharimmune Corporation) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Inc|Revenue and Sales Volume GNPX|Company Sales Calidi Biotherapeutics Inc. CLDI|Company Revenue Sunshine Biopharma Inc. SBFM|Company Gross Revenue Xenetic Biosciences (XBIO)|SLRX - Company Revenue|Company Total Revenue Kitov Pharma|BGNE: Revenue and Sales Volume|Company Sales checkpointtx.com|Company Revenue Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Company Gross Revenue|Company Revenue Ikena (IKNA)|NTBL - Company Total Revenue|Company Revenue viracta.com VIRX|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue